BioCentury
ARTICLE | Financial News

Navidea completes debt financing

July 1, 2013 7:00 AM UTC

Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Date completed: 6/25/13 Type: Debt financing Raised: $25 million Investors: GE Capital; MidCap Financial Note: The seni...